Articles by Disease (Spinal Cord Diseases)

Leptin Transport Across the Blood-Brain Barrier: Implications for the Cause and Treatment of Obesity

Journal: Current Pharmaceutical Design
Volume: 7
Page: 125-133
Author(s): William A. Banks

Involvement of Tachykinins in Intestinal Inflammation

Journal: Current Pharmaceutical Design
Volume: 7
Page: 19-30
Author(s): S. Evangelista

The Use of TNF Family Ligands and Receptors and Agents which Modify their Interaction as Therapeutic Agents

Journal: Current Drug Targets
Volume: 1
Page: 327-364
Author(s): M. Gardnerova, R. Blanque and C. R. Gardner

A Survey of Calpain Inhibitors

Journal: Current Medicinal Chemistry
Volume: 7
Page: 1171-1188
Author(s): I. O. Donkor

Normal and Pathological Erectile Function The Potential Clinical Role of Endothelin-1 Antagonists

Journal: Current Drug Targets
Volume: 1
Page: 247-260
Author(s): M. A. Khan, R. C. Calvert, M. E. Sullivan, C. S. Thomson, F. H. Mumtaz, R. J. Morgan and D. P. Mikhailidis

Structural Approaches to Explain the Selectivity of COX-2 Inhibitors: Is There a Common Pharmacophore?

Journal: Current Medicinal Chemistry
Volume: 7
Page: 1101-1112
Author(s): G. Dannhardt and S. Laufer

COX-2 in Brain and Spinal Cord - Implications for Therapeutic Use.

Journal: Current Medicinal Chemistry
Volume: 7
Page: 1113-1120
Author(s): C. Hoffmann

COX-2 Selectivity and Inflammatory Processes

Journal: Current Medicinal Chemistry
Volume: 7
Page: 1145-1161
Author(s): Joanne van Ryn, Gnnter Trummlitz and Michel Pairet

Clinical Experience with Specific COX-2 Inhibitors in Arthritis

Journal: Current Pharmaceutical Design
Volume: 6
Page: 1725-1736
Author(s): Leslie J. Crofford

Cyclooxygenases in the Central Nervous System: Implications for Treatment of Neurological Disorders

Journal: Current Pharmaceutical Design
Volume: 6
Page: 1755-1776
Author(s): A. Yermakova and M. K. O'Banion